Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Image-defined risk factors predict surgical outcomes in paediatric neuroblastic tumours
Image-defined risk factors predict surgical outcomes in paediatric neuroblastic tumours

New developments in molecular imaging

Prof Wim Oyen – Radboud University Nijmagen Medical Centre, Netherlands
New developments in molecular imaging ( Prof Wim Oyen – Radboud University Nijmagen Medical Centre, Netherlands )
5 Oct 2012

Personalised cancer medicine and research: Today’s best practice

Prof José Baselga - Massachusetts General Hospital, Boston, USA
Personalised cancer medicine and research: Today’s best practice ( Prof José Baselga - Massachusetts General Hospital, Boston, USA )
5 Oct 2012

Treating liver metastases in colorectal cancer

Dr Gunnar Folprecht - University Cancer Center, Dresden, Germany
Treating liver metastases in colorectal cancer ( Dr Gunnar Folprecht - University Cancer Center, Dresden, Germany )
4 Oct 2012

Putting drugs to work against brain metastases in HER2 positive breast cancer: LANDSCAPE study

Dr Thomas Bachelot – Centre Leon Berard, Lyon
Putting drugs to work against brain metastases in HER2 positive breast cancer: LANDSCAPE study ( Dr Thomas Bachelot – Centre Leon Berard, Lyon )
4 Oct 2012

The Multinational Association of Supportive Care in Cancer (MASCC)

Dr Stephen Grunberg – University of Vermont, Burlington, USA
The Multinational Association of Supportive Care in Cancer (MASCC) ( Dr Stephen Grunberg – University of Vermont, Burlington, USA )
4 Oct 2012

Defining personalised medicine and patient empowerment

Prof Gabriella Pravettoni – University of Milan, Italy
Defining personalised medicine and patient empowerment ( Prof Gabriella Pravettoni – University of Milan, Italy )
4 Oct 2012

Phase I study examining PI 3 kinase inhibitor for various tumours

Dr Pamela Munster – University of California, San Francisco, USA
Phase I study examining PI 3 kinase inhibitor for various tumours ( Dr Pamela Munster – University of California, San Francisco, USA )
4 Oct 2012

Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
30 Sep 2012

A proof-of-concept study of ODM-201 in patients with progressive castration-resistant prostate cancer

Dr Christophe Massard - Institute Gustave Roussy, Paris, France
A proof-of-concept study of ODM-201 in patients with progressive castration-resistant prostate cancer ( Dr Christophe Massard - Institute Gustave Roussy, Paris, France )
30 Sep 2012

Too few women being offered breast-conserving treatment?

Dr Carmen Criscitiello - European Institute of Oncology in Milan, Italy
Too few women being offered breast-conserving treatment? ( Dr Carmen Criscitiello - European Institute of Oncology in Milan, Italy )
30 Sep 2012

Personalised medicine: Hype or hope?

Jola Gore Booth - Europacolon
Personalised medicine: Hype or hope? ( Jola Gore Booth - Europacolon )
30 Sep 2012

Awareness of personalised medicine in cancer patients

Dr Sabine Tejpar - University Hospital Gasthuisberg, Lueven, Belgium
Awareness of personalised medicine in cancer patients ( Dr Sabine Tejpar - University Hospital Gasthuisberg, Lueven, Belgium )
30 Sep 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation